[Congestive splenomegaly of the Mediterranean type and consumption coagulopathy. II. Demonstration of chronic intravascular coagulation in Mediterranean-type congestive splenomegaly].
D000925:Anticoagulants; D001778:Blood Coagulation Disorders / Q000150:complications*; D004211:Disseminated Intravascular Coagulation / Q000150:complications; D005165:Factor V / Q000378:metabolism; D005342:Fibrinolysis; D006474:Hemorrhagic Disorders / Q000188:drug therapy*; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D006975:Hypertension, Portal; D008099:Liver / Q000378:metabolism; D013163:Splenomegaly / Q000209:etiology*; D013921:Thrombocytopenia / Q000150:complications; D013997:Time Factors
D000925:Anticoagulants; D005165:Factor V; D006493:Heparin
Splénomégalies congestives méditerranéennes et coagulopathie de consommation. II. Mise en évidenced'un processus de coagulation intravascularire chronique dans les splénomégalies méditerranéennes.